[Terodiline in the treatment of stress incontinence in women].
Terodiline combines simultaneously a parasympatholytic and a calcium antagonistic effect and can be used positively for the treatment of urge-incontinence of women. 44 female patients with an urge-incontinence have been examined urodynamically before and after a six-week treatment with terodiline. After therapy the urodynamic parameters ameliorated significantly. A subjective amelioration or even a healing of the urge symptomatic occurred in 86.4% of the patients. The side effects were minor.
Feyereisl
J
J
Universitäts-Frauenklinik Bern.
Hänggi
W
W
Dreher
E
E
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002082:Butylamines / Q000009:adverse effects / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*; D014550:Urinary Incontinence, Stress / Q000188:drug therapy*
D002082:Butylamines; D002121:Calcium Channel Blockers; D010276:Parasympatholytics; C010637:terodiline
Terodilin in der Behandlung der Dranginkontinenz Frau.